Medication info

New Mokcura 375 mg (Amoxicillin-Potassium Clavulanate)

Prescription medicationTabletOralExpired
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
AhnGuk New Pharm Co., Ltd.
Appearance
White or nearly white oval film-coated tablets.
Packaging
100 tablets (10 tablets/PTPX10), 96 tablets (8 tablets/PTPX12), 80 tablets (8 tablets/PTPX10)
Approval status
Expired

MFDS item code 201900861 · Approved 2019.02.11

This product's status changed to Expired on 2024.02.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
AhnGuk New Pharm Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medicine is effective for the treatment of infections caused by various bacteria. It is used for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, and lung abscess. It also helps with upper respiratory infections such as tonsillitis, sinusitis, and otitis media. Additionally, it is effective for the treatment of urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is used for skin and soft tissue infections such as pelvic infections, gonorrhea, boils and abscesses, cellulitis, and wound infections. It is also utilized in the treatment of osteomyelitis and dental infections, significantly contributing to patient recovery. This medicine is very useful for treating diverse and wide-ranging bacterial infections.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Precautions

This medicine contains components belonging to the beta-lactam antibiotic class, including penicillin. This medicine should not be used in patients who have had hypersensitivity reactions to this component or beta-lactam antibiotics. Caution is especially needed in patients with a history of anaphylaxis, severe skin reactions, or shock. Patients with viral infections such as infectious mononucleosis or lymphocytic leukemia may have an increased risk of rash and other side effects when using this medicine, so it should be avoided in such cases. Patients who have experienced liver dysfunction or jaundice due to this medicine or penicillin-class drugs should avoid use due to the risk of recurrence. Patients with impaired liver function should be treated cautiously, as this medicine can worsen liver function. Patients with moderate to severe renal impairment need dose adjustments due to the risk of prolonged drug retention and increased concentrations. Patients with a history of allergic reactions, bronchial asthma, skin rashes, hives, and other past incidents should be cautious when using this medicine. Patients with gastrointestinal conditions such as vomiting or diarrhea may not absorb the medicine efficiently, so careful administration is essential. During the use of this medicine, if gastrointestinal symptoms like diarrhea, abdominal pain, or bloody stools occur, discontinue use immediately and consult a doctor. This is because serious colitis, such as membranous colitis, may develop. Prolonged use may require regular liver function tests as abnormal liver function tests and symptoms of jaundice may occur. Severe skin reactions such as rashes, itching, and in severe cases, Stevens-Johnson syndrome, may occur due to allergic reactions; therefore, discontinue use immediately if any unusual signs appear. Blood tests may rarely show abnormalities such as leukopenia, thrombocytopenia, or anemia, thus requiring blood tests during long-term use. Psychiatric symptoms like anxiety, confusion, and convulsions have been reported infrequently, particularly in patients with impaired kidney function or when administered in high doses. Regular kidney function tests are necessary for patients with kidney diseases, as this medicine may affect kidney function. This medicine may alter intestinal flora, potentially leading to oral thrush or candidiasis; consultation with a doctor is advised if symptoms appear. A tendency to bleed due to vitamin K deficiency may appear, so special caution is advised for elderly patients or those at risk of vitamin K deficiency. This medicine may interact with other drugs, especially anticoagulants, probenecid, allopurinol, and other antibiotics; consultation with a healthcare professional is necessary when combined with these medications. It is generally safe for pregnant women to avoid use of this medication during the first three months unless in special circumstances. Breastfeeding mothers should be cautioned as the drug's components can pass into breast milk, potentially causing symptoms like diarrhea or skin rash in the infant, and should discontinue use if such symptoms appear. Use is not recommended in children under 12 years of age or weighing less than 40 kg due to limited experience. Elderly patients are at higher risk of adverse effects due to decreased kidney and liver function; therefore, careful dosing and intervals are advised.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stool, dry mouth, candidiasis, antibiotic-induced colitis, bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, antispasmodic, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, decreased urination, interstitial epilepsy, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in an airtight container to prevent moisture and kept in a cool, dry place below 25 degrees Celsius. Proper storage can help maintain the medicine's effectiveness for a longer time.

Appearance and packaging

Appearance

White or nearly white oval film-coated tablets.

Package unit

100 tablets (10 tablets/PTPX10), 96 tablets (8 tablets/PTPX12), 80 tablets (8 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.